GlassScriptPhysician profile
William D Lucky
NPI 1538168075
$4,172.62
in general payments reported to CMS, 2019-2025
19 companies · $1,670 in 2025
The $1,670 reported for 2025 was more than what 92% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,282 · 2020: $204 · 2021: $74.79 · 2022: $254 · 2023: $209 · 2024: $479 · 2025: $1,670.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,346 · Travel and Lodging: $695 · Education: $317.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,345.81 |
| Travel and Lodging | $695.37 |
| Education | $316.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $1,311.90 | 2024-2025 | Kerecis Surgiclose, Kerecis Graftguide, Kerecis Omega3 Marigen |
| Smith+Nephew, INC. | $894.98 | 2019-2024 | Collagenase Santyl, Renasys Go V2 Home, Regranex |
| Organogenesis INC. | $681.13 | 2019-2025 | Simplimax, Via Matrix, Puraply Am |
| Ets Wound Care LLC | $351.54 | 2024 | Mirragen Advanced Wound Matrix |
| Angiodynamics, INC. | $314.21 | 2019 | |
| Integra Lifesciences Corporation | $188.16 | 2019-2025 | Tcc-Ez |
| Aroa Biosurgery Incorporated | $140.79 | 2025 | |
| Paratek Pharmaceuticals, INC. | $51.31 | 2022-2023 | Nuzyra |
| Melinta Therapeutics, LLC | $43.77 | 2019 | |
| Convatec INC. | $32.22 | 2020-2021 | |
| Kci USA, INC. | $29.52 | 2021-2022 | |
| Abbvie INC. | $23.33 | 2023 | |
| Urgo Medical North America, LLC | $19.19 | 2023 | Urgok2, Drawtex Hydroconductive Wound Dressing With Levafiber 4x4, Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
| Medtronic Vascular, INC. | $18.63 | 2019 | |
| Bioventus LLC | $16.89 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $16.31 | 2023 | Xarelto |
| Bsn Medical INC | $15.36 | 2022 | |
| Acell, INC. | $11.87 | 2019 | |
| Osiris Therapeutics INC. | $11.51 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Lucky listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.